Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention

Authors :: Sara Ariotti
Stephan Windecker
Giuseppe Gargiulo
Aris Moschovitis
Anna Franzone
Raffaele Piccolo
Andrea Santucci
Andrea Baldo
Marco Valgimigli
Carlo Tumscitz
Piccolo, Raffaele
Gargiulo, Giuseppe
Franzone, Anna
Santucci, Andrea
Ariotti, Sara
Baldo, Andrea
Tumscitz, Carlo
Moschovitis, Ari
Windecker, Stephan
Valgimigli, Marco
Source :: Annals of internal medicine. 167(1)
Publication Year :: 2017
Abstract: Background The dual-antiplatelet therapy (DAPT) score was developed to identify patients more likely to derive harm (score

Subjects :: Male
medicine.medical_treatment
Myocardial Infarction
Coronary Artery Disease
030204 cardiovascular system & hematology
law.invention
Coronary artery disease
0302 clinical medicine
Randomized controlled trial
Retrospective Studie
law
Cardiovascular Disease
Stent
030212 general & internal medicine
Myocardial infarction
610 Medicine & health
General Medicine
Middle Aged
Clopidogrel
Treatment Outcome
Cardiovascular Diseases
Cardiology
Platelet aggregation inhibitor
Female
Stents
Human
medicine.drug
medicine.medical_specialty
animal structures
Ticlopidine
Hemorrhage
Drug Administration Schedule
03 medical and health sciences
Percutaneous Coronary Intervention
Internal medicine
Internal Medicine
medicine
Humans
Aged
Retrospective Studies
Aspirin
business.industry
Platelet Aggregation Inhibitor
Percutaneous coronary intervention
medicine.disease
Regimen
business
Platelet Aggregation Inhibitors

Tools